InvestingBiotech ETF Rises 23% as Drug Milestones Span Trials to ApprovalBy Celia RowanOct 24, 2026, 7:11 PM UTC
HealthWeek 37 Data Show 43.1% Lower Proteinuria With Roche's IgA DrugBy Naomi CalderOct 24, 2026, 4:30 AM UTC
HealthRoche Signs Conditional Global License Deal for Zymeworks’ ZW209 ProgramBy Naomi CalderOct 23, 2026, 8:34 PM UTC
BusinessRoche Pharma Sales Beat Q3 Consensus Forecast by CHF 350 MillionBy Helena WardOct 23, 2026, 5:56 PM UTC
HealthRoche Prepares Giredestrant Launch Ahead of Two FDA Review DatesBy Naomi CalderOct 22, 2026, 3:43 PM UTC
BusinessRoche Posts 8% Third-Quarter Sales Growth in Swiss FrancsBy Helena WardOct 22, 2026, 1:21 PM UTC
Market RoundupsRoche ties future investment to countries rewarding innovationBy Adrian ValeOct 22, 2026, 1:06 PM UTC
HealthFDA Approves GSK's Hibsago for Some Adults With Chronic Hepatitis BBy Naomi CalderOct 21, 2026, 5:07 AM UTC
